Sunday, July 3, 2022

In Elizabeth Holmes Trial, U.S. Gave Patients a Small Stage - The Wall Street Journal

Prosecutors proved that Theranos Inc. founder Elizabeth Holmes defrauded big-name investors about the capabilities of her blood-testing startup. But their charges involving lower-profile patients fell flat after the government gave them a smaller stage at the trial.

At the heart of the case was the argument that Ms. Holmes attracted hundreds of millions of dollars from investors after launching patient-testing services that she falsely promised were ready for prime time, and she disregarded the chaos its inaccurate results could inflict on patient lives. In the end, Theranos voided tens of thousands of test results under pressure from regulators.

Read Full Story: https://www.wsj.com/articles/in-elizabeth-holmes-trial-u-s-gave-patients-a-small-stage-11641329202